MID-VOLUME · HOSP-HEAVY
remdesivir Side Effects
remdesivir (also sold as Veklury) sits MID-VOLUME #285 of 524 by FAERS report count. Lead signal: HOSP-HEAVY - 33.8% mention hospitalization (4,426 reports). Demographics and serious-outcome tables follow.
Data updated 2026-05-15
- 13,113
- FAERS reports
FDA Adverse Event Reporting System extract for remdesivir. Stamp set WATCHLIST · DEATH-HEAVY · HOSP-HEAVY. How figures are compiled.
remdesivir: 33.8% mention hospitalization (4,426 reports). Death stamp DEATH-HEAVY; volume band MID-VOLUME #285 of 524 by FAERS report count.
Mid-book FAERS page for remdesivir (Veklury) (13,113 reports). Signature HOSP-HEAVY. Dominant age band on file: 45-64. Educational reference only.
Counts from the openFDA FAERS extract (2018–2025). Stamps WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ALANINE AMINOTRANSFERASE INCREASED leads 933 of 13,113 reports
Who reports · age peak 45-64 (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 45-64 (3,630 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (3,250 reports, 24.8%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| DEATH | 747 |
| COVID-19 | 397 |
| RESPIRATORY FAILURE | 334 |
| ACUTE KIDNEY INJURY | 253 |
| CARDIAC ARREST | 220 |
| MULTIPLE ORGAN DYSFUNCTION SYNDROME | 214 |
| COVID-19 PNEUMONIA | 203 |
| SEPTIC SHOCK | 194 |
| HYPOXIA | 158 |
| CONDITION AGGRAVATED | 150 |
| HYPOTENSION | 114 |
| ACUTE RESPIRATORY DISTRESS SYNDROME | 111 |
| PNEUMONIA | 111 |
| SEPSIS | 111 |
| RENAL FAILURE | 110 |
| ACUTE RESPIRATORY FAILURE | 107 |
| DRUG INEFFECTIVE FOR UNAPPROVED INDICATION | 102 |
| GENERAL PHYSICAL HEALTH DETERIORATION | 86 |
Reactions in Hospitalization Reports
Hospitalization is HEAVY (4,426, 33.8% of the book). Top reactions in those rows:
| Reaction | Reports |
|---|---|
| COVID-19 | 557 |
| COVID-19 PNEUMONIA | 314 |
| DRUG INEFFECTIVE FOR UNAPPROVED INDICATION | 283 |
| RESPIRATORY FAILURE | 241 |
| ACUTE KIDNEY INJURY | 228 |
| PNEUMONIA | 175 |
| BRADYCARDIA | 164 |
| SEPTIC SHOCK | 148 |
| DRUG INTERACTION | 145 |
| CONDITION AGGRAVATED | 142 |
| BRONCHOPULMONARY ASPERGILLOSIS | 124 |
| DYSPNOEA | 118 |
| DEATH | 117 |
| MULTIPLE ORGAN DYSFUNCTION SYNDROME | 111 |
| ALANINE AMINOTRANSFERASE INCREASED | 110 |
| RENAL IMPAIRMENT | 105 |
| CARDIAC ARREST | 104 |
| ASPARTATE AMINOTRANSFERASE INCREASED | 101 |
How to read remdesivir FAERS figures (WATCHLIST · DEATH-HEAVY · HOSP-HEAVY)
FAERS holds 13,113 voluntary reports linked to remdesivir (Veklury), 2018-2025. Death is listed on 3,250 (24.8%). Hospitalization appears on 4,426 (33.8%). Top co-reported indication: Covid-19.
Mid-volume extract - treat DEATH-HEAVY · HOSP-HEAVY as signal-detection rates next to 33.8% mention hospitalization (4,426 reports).
Read with remdesivir
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-HEAVY stamps.
ABS(total_reports) peer at 13,075 FAERS cases (Δ 38 lighter vs remdesivir); DEATH-MARKED · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 12,966 FAERS cases (Δ 147 lighter vs remdesivir); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 12,919 FAERS cases (Δ 194 lighter vs remdesivir); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 13,367 FAERS cases (Δ 254 heavier vs remdesivir); DEATH-HEAVY · HOSP-HEAVY · FEMALE-LED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 37.3 pp vs remdesivir's DEATH-HEAVY): CASELOAD · HOSP-MID.
remdesivir stamps DEATH-HEAVY · HOSP-HEAVY; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload WATCHLIST and the label guide.